|
Variable
|
Univariable analysis
|
P-Value
|
Multivariable analysis
|
P-value
|
|---|
|
COR (95% CI)
|
AOR (95% CI)
|
|---|
|
Age (years)
|
|
29–39
|
1
| |
1
| |
|
40–50
|
1.7(0.34–8.15)
|
0.529
|
2.4(0.32–17.61)
|
0.412
|
|
≥ 51
|
1.5(0.32–6.39)
|
0.625
|
1.7(0.24–11.52)
| |
|
Education
|
|
Illiterate
|
1
| |
1
| |
|
Literate
|
2.8(0.54–14.11)
|
0.221
|
4.2(0.60–30.01)
|
0.161
|
|
Marital status
|
|
Single
|
1
| |
1
| |
|
Married
|
1.6(0.54–4.82)
|
0.386
|
1.2(0.42–3.71)
|
0.761
|
|
Co-morbidity
|
|
No
|
1
| |
1
| |
|
Yes
|
0.4(0.17–1.11)
|
0.084
|
0.4(0.11–1.32)
|
0.125
|
|
Number of medications
|
|
< 5
|
1
| |
1
| |
|
≥ 5
|
3.2(1.15–8.73)
|
0.026*
|
3.6(1.24–11.23)
|
0.026*
|
|
Type of cancer
|
|
Adenocarcinoma & Invasive anaplastic carcinoma
|
1
| |
1
| |
|
Squamous cell carcinoma
|
1.6(0.29–8.96)
|
0.586
|
1.5(0.32–7.43)
|
0.614
|
|
Stage of cervical cancer
| | | | |
|
Early stage
|
1
| |
1
| |
|
Advanced stage
|
2.3(0.58–9.33)
|
0.231
|
3.2(0.72–13.62)
|
0.121
|
|
Treatment Regimen
|
|
Cisplatin + Paclitaxel
|
3.7(0.9–16.5)
|
0.079
|
9.8(1.25–77.81)
|
0.030*
|
-
COR Crude odds ratio, AOR Adjusted odds ratio, 95% CI 95% confidence interval, *Statistically significant: P value ≤0.05
